CPIM
IDXX icon

Coalescence Partners Investment Management’s Idexx Laboratories IDXX Stock Holding History

Coalescence Partners Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
26,776
+8,217
+44% +$4.61M 4.14% 10
2026
Q1 		$10.4M Hold
18,559
– – 2.25% 12
2025
Q4 		$12.6M Hold
18,559
– – 2.96% 12
2025
Q3 		$11.9M Sell
18,559
-19,147
-51% -$11.6M 3.09% 12
2025
Q2 		$20.2M Buy
+37,706
New +$18M 5.22% 13

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Coalescence Partners Investment Management's IDXX Position: Q2 2026 in Review

Coalescence Partners Investment Management increased its Idexx Laboratories (IDXX) stake by 44% in Q2 2026, buying an estimated $4.61M and bringing the position to 26,776 shares worth $14.1M. The position accounts for 4.14% of the portfolio, ranked #10.

Coalescence Partners Investment Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $20.2M in Q2 2025. 1,292 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Coalescence Partners Investment Management held 26,776 shares of Idexx Laboratories worth $14.1M as of Q2 2026.
  • Coalescence Partners Investment Management bought 8,217 Idexx Laboratories shares in Q2 2026, an estimated $4.61M.
  • Idexx Laboratories made up 4.14% of Coalescence Partners Investment Management's portfolio in Q2 2026, its #10 holding.
  • Coalescence Partners Investment Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Coalescence Partners Investment Management's Idexx Laboratories position peaked at $20.2M in Q2 2025.
  • 1,292 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Coalescence Partners Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.